Cargando…
SMILES-based 2D-QSAR and similarity search for identification of potential new scaffolds for development of SARS-CoV-2 MPRO inhibitors
COVID-19, whose etiological agent is the SARS-CoV-2 virus, has caused over 537.5 million cases and killed over 6.3 million people since its discovery in 2019. Despite the recent development of the first drugs indicated for treating people already infected, the great need to develop new anti-SARS-CoV...
Autores principales: | Costa, Adriana Santos, Martins, João Paulo Ataide, de Melo, Eduardo Borges |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer US
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9257568/ https://www.ncbi.nlm.nih.gov/pubmed/35811781 http://dx.doi.org/10.1007/s11224-022-02008-9 |
Ejemplares similares
-
A QSAR Study of Matrix Metalloproteinases Type 2 (MMP-2) Inhibitors with Cinnamoyl Pyrrolidine Derivatives
por: de Melo, Eduardo Borges
Publicado: (2012) -
QSAR-derived affinity fingerprints (part 1): fingerprint construction and modeling performance for similarity searching, bioactivity classification and scaffold hopping
por: Škuta, C., et al.
Publicado: (2020) -
Advances in the Development of SARS-CoV-2 Mpro Inhibitors
por: Agost-Beltrán, Laura, et al.
Publicado: (2022) -
Investigation of Thiocarbamates as Potential Inhibitors of the SARS-CoV-2 Mpro
por: Papaj, Katarzyna, et al.
Publicado: (2021) -
Binding of inhibitors to the monomeric and dimeric SARS-CoV-2 Mpro
por: Tam, Nguyen Minh, et al.
Publicado: (2021)